Toyama, Japan

Mikako Miyajima



Average Co-Inventor Count = 8.9

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Toyma, JP (1991)
  • Toyama, JP (1987 - 2002)

Company Filing History:


Years Active: 1987-2002

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mikako Miyajima: Innovator in Pharmaceutical Chemistry

Introduction

Mikako Miyajima is a prominent inventor based in Toyama, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 4 patents to her name, her work focuses on addressing critical health issues.

Latest Patents

Mikako's latest patents include groundbreaking inventions such as spiro compounds or salts thereof, which serve as preventives and remedies for autoimmune diseases. Additionally, she has developed AP-1 inhibitors containing pyridone carboxylic acid derivatives and salts thereof. This invention relates to a novel pyridone carboxylic acid derivative that features a substituted or unsubstituted cyclopropyl group at the 10-position of pyridobenzoxazine, pyridobenzothiazine, or pyridoquinoxaline, along with a process for its production and an antibacterial agent comprising the same.

Career Highlights

Mikako Miyajima is currently employed at Toyama Chemical Co., Ltd., where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options that can significantly improve patient outcomes.

Collaborations

Throughout her career, Mikako has collaborated with esteemed colleagues, including Yozo Todo and Hirokazu Narita. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new medical solutions.

Conclusion

Mikako Miyajima's contributions to pharmaceutical chemistry exemplify her dedication to innovation and improving healthcare. Her patents reflect her commitment to addressing complex medical challenges through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…